SEC Form 4 · accession 0001127602-19-009104

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chairman, President and CEO · Director

Period of report

Feb 27, 2019

Accepted (ET)

Mar 1, 2019 · 11:19 am EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001100682

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Feb 27, 2019	S	100	$141.12	D	288,887	D
Common Stock	Feb 27, 2019	S	100	$141.15	D	288,787	D
Common Stock	Feb 27, 2019	S	32	$141.18	D	288,755	D
Common Stock	Feb 27, 2019	S	200	$141.19	D	288,555	D
Common Stock	Feb 27, 2019	S	11	$141.255	D	288,544	D
Common Stock	Feb 27, 2019	S	33	$141.26	D	288,511	D
Common Stock	Feb 27, 2019	S	24	$141.265	D	288,487	D
Common Stock	Feb 27, 2019	S	30	$141.31	D	288,457	D
Common Stock	Feb 27, 2019	S	400	$141.32	D	288,057	D
Common Stock	Feb 27, 2019	S	100	$141.34	D	287,957	D
Common Stock	Feb 27, 2019	S	100	$141.36	D	287,857	D
Common Stock	Feb 27, 2019	S	200	$141.38	D	287,657	D
Common Stock	Feb 27, 2019	S	66	$141.40	D	287,591	D
Common Stock	Feb 27, 2019	S	200	$141.425	D	287,391	D
Common Stock	Feb 27, 2019	S	200	$141.435	D	287,191	D
Common Stock	Feb 27, 2019	S	100	$141.46	D	287,091	D
Common Stock	Feb 27, 2019	S	38	$141.47	D	287,053	D
Common Stock	Feb 27, 2019	S	4	$141.49	D	287,049	D
Common Stock	Feb 27, 2019	S	200	$141.52	D	286,849	D
Common Stock	Feb 27, 2019	S	31	$141.525	D	286,818	D
Common Stock	Feb 27, 2019	S	200	$141.54	D	286,618	D
Common Stock	Feb 27, 2019	S	30	$141.57	D	286,588	D
Common Stock	Feb 27, 2019	S	300	$141.58	D	286,288	D

No Table II lines on this filing.